Research programme: anti-interleukin-1 antibody - Roche

Drug Profile

Research programme: anti-interleukin-1 antibody - Roche

Alternative Names: 35F5

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antibodies
  • Mechanism of Action Interleukin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Viral infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in United Kingdom (IV)
  • 21 May 2008 Preclinical trials in Viral infections in United Kingdom (IV)
  • 21 May 2008 Preclinical pharmacodynamics data from a trial in COPD-like viral exacerbation presented at the 104th International Conference of the American Thoracic Society (ATS-2008)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top